|
|
 |
Volume 3, Issue 3 (1-2012) |
 |
|
|
|
|
PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions
|
Miroslaw J. Szczepanski *   , Albert B. DeLeo , Michał Łuczak , Marta Molinska-Glura , Jan Misiak , Bronislawa Szarzynska , Grzegorz Dworacki , Mariola Zagor , Natalia Rozwadowska , Theresa L. Whiteside |
| Department of Clinical Immunology, University of Medical Sciences, Poznan, Poland |
|
|
Abstract: (3113 Views) |
| This article has no abstract. |
|
| |
|
|
|
Type of Study: Research |
Subject:
Oral Medicine
Received: 2013/11/17 | Accepted: 2013/11/17 | Published: 2013/11/17
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
|
J. Szczepanski M, B. DeLeo A, Łuczak M, Molinska-Glura M, Misiak J, Szarzynska B, et al . PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions. 3 2012; 3 (3) URL: http://idai.ir/article-1-2462-en.html
|
|
|
|
|
|
